Human clinical trials could begin as early as next year
A team of researchers at the University of Georgia’s Regenerative Bioscience Center and ArunA Biomedical, a UGA startup company, have developed a new treatment for stroke that reduces brain damage and accelerates the brain’s natural healing tendencies in animal models. They published their findings in the journal Translational Stroke Research.
The research team led by UGA professor Steven Stice and Nasrul Hoda of Augusta University created a treatment called AB126 using extracellular vesicles (EV), fluid-filled structures known as exosomes, which are generated from human neural stem cells.
Fully able to cloak itself within the bloodstream, this type of regenerative EV therapy appears to be the most promising in overcoming the limitations of many cell therapies—with the ability for exosomes to carry and deliver multiple doses—as well as the ability to store and administer treatment. Small in size, the tiny tubular shape of an exosome allows EV therapy to cross barriers that cells cannot.
“This is truly exciting evidence, because exosomes provide a stealth-like characteristic, invisible even to the body’s own defenses,” said Stice, Georgia Research Alliance Eminent Scholar and D.W. Brooks Distinguished Professor in the College of Agricultural and Environmental Sciences. “When packaged with therapeutics, these treatments can actually change cell progression and improve functional recovery.”
Following the administration of AB126, the researchers used MRI scans to measure brain atrophy rates in preclinical, age-matched stroke models, which showed an approximately 35 percent decrease in the size of injury and 50 percent reduction in brain tissue loss—something not observed acutely in previous studies of exosome treatment for stroke.
Outside of rodents, the results were replicated by Franklin West, associate professor of animal and dairy science, and fellow RBC members using a porcine model of stroke—the only one of its kind in the U.S.
Based on these pre-clinical results, ArunA Biomedical plans to begin human studies in 2019, said Stice, who is also chief scientific officer of ArunA Biomedical.
“Until now, we had very little evidence specific to neural exosome treatment and the ability to improve motor function,” said Stice. “Just days after stroke, we saw better mobility, improved balance and measurable behavioral benefits in treated animal models.”
Named as part of the ‘stroke belt’ region, Georgia continues to exceed the national average in stroke deaths, which is the third leading cause of death in the U.S., with more than 140,000 Americans dying each year, according to the Centers for Disease Control and Prevention.
ArunA recently unveiled advances to the company’s proprietary neural cell platform for the production of exosome manufacturing. Today, ArunA’s manufacturing process positions the company to produce AB126 exosomes at a scale to meet early clinical demand. The company has plans to expand this initiative beyond stroke for preclinical studies in epilepsy, traumatic brain and spinal cord injuries later this year.
The Latest on: Stroke treatment
- Acute Ischemic Stroke Diagnosis and Treatment Market Report - Market Size, Share, Sales, Growth And Forecast To 2023 on December 18, 2018 at 9:02 pm
report 2018-2023 begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Acute Ischemic Stroke Diagnosis and Treatment by ... […]
- Rising High Blood Pressure Patients to Accelerate the Global Stroke Disorder and Treatment Market During the Forecast Period (2016-2022) on December 18, 2018 at 5:27 am
The Global Stroke Disorder And Treatment Market is presumed to demonstrate a healthy CAGR during the forecast period (2016-2022) owing to the rising high blood pressure patients, asserts Market Resear... […]
- Telemedicine speeds up stroke treatment at Alton Memorial Hospital on December 17, 2018 at 1:55 pm
ALTON – Alton Memorial Hospital now has real-time access to some of the nation’s top stroke experts — even when they’re not on-site. AMH has begun using stroke telemedicine to receive direct care cons... […]
- Preclinical Results Showed Synergistic Benefits in Administration of TSC with Tissue Plasminogen Activator (tPA) for Treatment of Stroke on December 17, 2018 at 6:59 am
... in patients suffering from ischemic stroke – is the only FDA-approved therapeutic stroke treatment. Worldwide, stroke is the second leading cause of death and is responsible for an ... […]
- Heat Stroke: Symptoms and Treatment on December 17, 2018 at 5:48 am
Heat stroke is the most serious form of heat injury and is considered a medical emergency. If you suspect that someone has heat stroke-- also known as sunstroke -- call 911 immediately and give first ... […]
- Bioxytran, Inc. Pioneers First Emergency Stroke Treatment on December 17, 2018 at 4:00 am
BOSTON, MASSACHUSETTS, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Bioxytran Inc. (BIXT). Dr. David Platt, CEO of newly formed company Bioxytran Inc, a developmental stage biotechnology company, recently ... […]
- Researchers investigate treatment for post-stroke depression on December 13, 2018 at 11:18 am
West Virginia University researchers are tapping into treatment options for a relatively unexplored disorder — post-stroke depression, a type of depression that stems from the cardiovascular changes i... […]
- New UGA study points to optimal hypertension treatment for stroke patients on December 10, 2018 at 8:49 pm
Aggressive treatment of hypertension in stroke patients could do more harm than good in the long term, according to a new study from researchers at the University of Georgia. Sixty percent of stroke p... […]
- Aggressive Treatment of Hypertension in Stroke Patients is Detrimental on December 10, 2018 at 7:58 pm
Treating hypertension aggressively in patients suffering from stroke can do more harm than good in the long run, reveals a finding by the scientists of University of Georgia. Sixty percent of stroke p... […]
- Study points to optimal blood pressure treatment for stroke patients on December 10, 2018 at 1:21 pm
Aggressive treatment of hypertension in stroke patients could do more harm than good in the long term, according to a new study from researchers at the University of Georgia. But lowering blood ... […]
via Google News and Bing News